Adaptive spectroscopic visible-light optical coherence tomography for clinical retinal oximetry

作者
Ian Rubinoff,Roman V. Kuranov,Raymond S. Fang,Zeinab Ghassabi,Yuanbo Wang,Lisa Beckmann,David A. Miller,Gadi Wollstein,Hiroshi Ishikawa,Joel S. Schuman,Hao F. Zhang
出处
期刊:Communications medicine [Nature Portfolio]
卷期号:3 (1): 57-57 被引量:35
标识
DOI:10.1038/s43856-023-00288-8
摘要

Abstract Background Retinal oxygen saturation (sO2) provides essential information about the eye’s response to pathological changes that can result in vision loss. Visible-light optical coherence tomography (vis-OCT) is a noninvasive tool that has the potential to measure retinal sO2 in a clinical setting. However, its reliability is currently limited by unwanted signals referred to as spectral contaminants (SCs), and a comprehensive strategy to isolate true oxygen-dependent signals from SCs in vis-OCT is lacking. Methods We develop an adaptive spectroscopic vis-OCT (ADS-vis-OCT) technique that can adaptively remove SCs and accurately measure sO2 under the unique conditions of each vessel. We also validate the accuracy of ADS-vis-OCT using ex vivo blood phantoms and assess its repeatability in the retina of healthy volunteers. Results In ex vivo blood phantoms, ADS-vis-OCT agrees with a blood gas machine with only a 1% bias in samples with sO2 ranging from 0% to 100%. In the human retina, the root mean squared error between sO2 values in major arteries measured by ADS-vis-OCT and a pulse oximeter is 2.1% across 18 research participants. Additionally, the standard deviations of repeated ADS-vis-OCT measurements of sO2 values in smaller arteries and veins are 2.5% and 2.3%, respectively. Non-adaptive methods do not achieve comparable repeatabilities from healthy volunteers. Conclusions ADS-vis-OCT effectively removes SCs from human images, yielding accurate and repeatable sO2 measurements in retinal arteries and veins with varying diameters. This work could have important implications for the clinical use of vis-OCT to manage eye diseases.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
晓风残月完成签到,获得积分10
刚刚
1秒前
合适的不言完成签到,获得积分10
2秒前
3秒前
晓风残月发布了新的文献求助10
3秒前
3秒前
啊突突突完成签到 ,获得积分10
4秒前
叶梦发布了新的文献求助10
4秒前
CH完成签到,获得积分10
4秒前
5秒前
5秒前
科研通AI6.2的应助被xiao_123123采纳,获得10
5秒前
marvel发布了新的文献求助10
6秒前
可爱的函函的应助被路痴采纳,获得10
6秒前
6秒前
我就吃一口完成签到 ,获得积分10
7秒前
寒冷的如曼完成签到 ,获得积分10
8秒前
bkagyin的应助被暖海采纳,获得10
8秒前
9秒前
6666669完成签到 ,获得积分10
9秒前
无私的遥发布了新的文献求助10
11秒前
11秒前
李沐阳完成签到,获得积分10
11秒前
Haley发布了新的文献求助10
12秒前
小马甲的应助被7733采纳,获得10
12秒前
万能图书馆的应助被不羡采纳,获得10
12秒前
REX完成签到,获得积分10
12秒前
宗忻发布了新的文献求助10
13秒前
13秒前
xiaobai完成签到,获得积分10
13秒前
李健的粉丝团团长的应助被kk采纳,获得10
14秒前
chang完成签到,获得积分10
14秒前
14秒前
lzl完成签到,获得积分10
15秒前
15秒前
16秒前
16秒前
yanaiqi完成签到 ,获得积分10
16秒前
深情安青的应助被朴实剑通采纳,获得10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Oncology Clinical Trials: Successful Design, Conduct, and Analysis, Second Edition 800
Stochastic Models in Operations Research,Vol. 2 600
Organizational Behavior 510
桑白皮エキスの実験的, 臨床的育毛効果について 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8044368
求助须知:如何正确求助?哪些是违规求助? 9476163
关于积分的说明 21282565
捐赠科研通 7612085
什么是DOI,文献DOI怎么找? 3391985
关于科研通互助平台的介绍 2523595
邀请新用户注册赠送积分活动 2429926